These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10521730)

  • 1. A five-year experience with fragile X screening of high-risk gravid women.
    Wenstrom KD; Descartes M; Franklin J; Cliver SP
    Am J Obstet Gynecol; 1999 Oct; 181(4):789-92. PubMed ID: 10521730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward prenatal screening and testing for Fragile X.
    Fanos JH; Spangner KA; Musci TJ
    Genet Med; 2006 Feb; 8(2):129-33. PubMed ID: 16481897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.
    Obstet Gynecol; 2010 Oct; 116(4):1008-1010. PubMed ID: 20859177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of a specialty clinic for individuals with fragile X syndrome.
    Visootsak J; Kidd SA; Anderson T; Bassell JL; Sherman SL; Berry-Kravis EM
    Am J Med Genet A; 2016 Dec; 170(12):3144-3149. PubMed ID: 27649377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fragile X syndrome: implications of molecular genetics for the clinical syndrome.
    Rousseau F
    Eur J Clin Invest; 1994 Jan; 24(1):1-10. PubMed ID: 8187801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics.
    Ryynänen M; Kirkinen P; Mannermaa A; Saarikoski S
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1236-9. PubMed ID: 7726262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
    Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
    Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in prenatal screening and counselling for fragile X syndrome.
    Mak AS; Leung KY
    Hong Kong Med J; 2017 Apr; 23(2):108-9. PubMed ID: 28387201
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular fragile X screening in normal populations.
    Spence WC; Black SH; Fallon L; Maddalena A; Cummings E; Menapace-Drew G; Bick DP; Levinson G; Schulman JD; Howard-Peebles PN
    Am J Med Genet; 1996 Jul; 64(1):181-3. PubMed ID: 8826471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile X mental retardation syndrome: DNA diagnosis and carrier detection in New Zealand families.
    Neville L; Cochrane J; Fitzgerald P; Kennedy M
    N Z Med J; 1995 Oct; 108(1009):404-6. PubMed ID: 7478333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic dilemmas and genetic counseling for prenatally detected fragile X gene expansions.
    Finucane B; Lincoln S; Bailey L; Martin CL
    Prenat Diagn; 2017 Jan; 37(1):37-42. PubMed ID: 27862088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of fragile X relatives with different attitudes toward terminating an affected pregnancy.
    Meryash DL
    Am J Ment Retard; 1992 Mar; 96(5):528-35. PubMed ID: 1562310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of prenatal population-based fragile X carrier screening.
    Musci TJ; Caughey AB
    Am J Obstet Gynecol; 2005 Jun; 192(6):1905-12; discussion 1912-5. PubMed ID: 15970847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of fragile X syndrome carrier screening during prenatal diagnosis: A pilot study at a single center.
    Xi H; Xie W; Chen J; Tang W; Deng X; Li H; Peng Y; Wang D; Yang S; Zhang Y; Duan R; Fang J; Wang H
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1711. PubMed ID: 34057320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.